- Service Name
MITRO Biotech
- Industry
Biotechnology, Pharmaceutical Services, CRO, CDMO
- Main Value Proposition
MITRO Biotech provides specialized and efficient services in radiolabeled molecular imaging, ensuring high-quality support for pharmaceutical and biopharmaceutical companies in their drug development processes.
- Description
MITRO Biotech specializes in providing professional and efficient CRO and CDMO services for radiolabeled molecular imaging in the global pharmaceutical and biopharmaceutical industries. The company offers a comprehensive one-stop solution for drug development, including radiolabeling, pharmacokinetics research, and clinical studies.
- Key Features
Comprehensive CRO and CDMO services for radiolabeled molecular imaging; Expertise in drug screening and pharmacokinetics research; One-stop solution for new drug development including clinical research; Global client base with over 700 clients served
- Use Cases
Pharmaceutical companies seeking to develop radiolabeled drugs; Research institutions requiring support in pharmacokinetics and drug screening; Biopharmaceutical firms needing comprehensive clinical research services
- Competitive advantages
Strong focus on nuclear medicine and radiolabeling expertise; Established track record with over 700 global clients; Comprehensive service offerings from preclinical to clinical research
- Strengths
MITRO Biotech's main strengths include its specialized knowledge in radiolabeling, a robust infrastructure for molecular imaging, and a commitment to providing high-quality, efficient services to its clients.
- Positioning
MITRO Biotech positions itself as a leading provider of CRDMO services in the nuclear medicine sector, focusing on the needs of the pharmaceutical and biopharmaceutical industries.
- Audience
The primary target users include pharmaceutical companies, biopharmaceutical firms, and research institutions that require specialized services in drug development and molecular imaging.
- CTA
Learn more →
- Tags
CRO
CDMO
Molecular Imaging
Radiolabeling
- Tagline
Committed to becoming a global leader in nuclear medicine CRDMO services.
- Tone of Voice
Professional, authoritative, innovative
- Differentiation
MITRO Biotech stands out in the market by offering a unique combination of CRO and CDMO services specifically tailored for radiolabeled molecular imaging, backed by extensive experience and a global client network.
- Brand Positioning
The brand identity of MITRO Biotech is centered around innovation and expertise in nuclear medicine, aiming to be recognized as a trusted partner in drug development.
- Founded
2012-01-01